Surgery Partners, Inc. (NASDAQ:SGRY) Insider Harrison R. Bane Sells 56,315 Shares of Stock

Surgery Partners, Inc. (NASDAQ:SGRY) insider Harrison R. Bane sold 56,315 shares of the firm’s stock in a transaction that occurred on Friday, February 7th. The shares were sold at an average price of $25.64, for a total transaction of $1,443,916.60. Following the transaction, the insider now directly owns 107,037 shares in the company, valued at approximately $2,744,428.68. The trade was a 34.47 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website.

Surgery Partners Stock Down 0.9 %

Shares of SGRY stock opened at $25.58 on Tuesday. Surgery Partners, Inc. has a one year low of $19.50 and a one year high of $35.29. The company has a debt-to-equity ratio of 0.99, a current ratio of 1.80 and a quick ratio of 1.66. The stock has a fifty day moving average price of $21.84 and a 200 day moving average price of $26.93. The stock has a market cap of $3.25 billion, a P/E ratio of -53.29, a price-to-earnings-growth ratio of 17.77 and a beta of 2.60.

Surgery Partners (NASDAQ:SGRY) last released its quarterly earnings data on Tuesday, November 12th. The company reported $0.19 EPS for the quarter, missing analysts’ consensus estimates of $0.25 by ($0.06). The business had revenue of $770.40 million for the quarter, compared to the consensus estimate of $768.99 million. Surgery Partners had a positive return on equity of 2.85% and a negative net margin of 2.03%. Surgery Partners’s revenue was up 14.3% on a year-over-year basis. During the same period in the previous year, the business posted $0.15 earnings per share. Analysts predict that Surgery Partners, Inc. will post 0.71 earnings per share for the current year.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the business. KBC Group NV grew its stake in shares of Surgery Partners by 31.8% in the 3rd quarter. KBC Group NV now owns 2,385 shares of the company’s stock valued at $77,000 after purchasing an additional 576 shares during the period. Point72 Asia Singapore Pte. Ltd. raised its stake in Surgery Partners by 747.6% during the third quarter. Point72 Asia Singapore Pte. Ltd. now owns 3,831 shares of the company’s stock worth $124,000 after acquiring an additional 3,379 shares in the last quarter. MeadowBrook Investment Advisors LLC raised its stake in Surgery Partners by 16.6% during the fourth quarter. MeadowBrook Investment Advisors LLC now owns 10,280 shares of the company’s stock worth $218,000 after acquiring an additional 1,460 shares in the last quarter. Empowered Funds LLC bought a new position in shares of Surgery Partners during the fourth quarter valued at $245,000. Finally, Creative Planning acquired a new stake in shares of Surgery Partners in the 3rd quarter valued at $258,000.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on SGRY. Macquarie reaffirmed an “outperform” rating and set a $34.00 target price on shares of Surgery Partners in a research report on Tuesday, November 19th. Royal Bank of Canada lowered their target price on shares of Surgery Partners from $49.00 to $35.00 and set an “outperform” rating on the stock in a research note on Wednesday, November 20th. UBS Group started coverage on shares of Surgery Partners in a report on Monday, October 14th. They issued a “buy” rating and a $38.00 target price on the stock. JPMorgan Chase & Co. decreased their price target on shares of Surgery Partners from $38.00 to $28.00 and set a “neutral” rating for the company in a report on Tuesday, December 3rd. Finally, Bank of America initiated coverage on Surgery Partners in a research note on Monday, December 16th. They issued a “buy” rating and a $30.00 price objective on the stock. One research analyst has rated the stock with a sell rating, three have given a hold rating and seven have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $36.56.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.